Head-to-Head

ABBVIE INC. vs. Rigel Pharmaceuticals Inc. (New)

ABBV

ABBVIE INC.

$250.33 +0.35%

VS RIGL

Rigel Pharmaceuticals Inc. (New)

$42.45 -0.31%

ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 9 compared factors.

Size & Scale

ABBVRIGL
Market Cap $440.83 billion $795.39 million
Revenue (TTM) $64.39 billion $276.79 million
Net Income (TTM) $6.32 billion $321.91 million

ABBV leads on 3 of 3 size & scale factors.

Valuation

ABBVRIGL
P/E Ratio 70.71 2.51
Price / Book -74.87 1.87
Price / Sales 6.85 2.87

RIGL leads on 2 of 3 valuation factors.

Profitability

ABBVRIGL
Net Margin 9.81% 116.30%
Return on Equity -107.29% 75.67%

RIGL leads on 2 of 2 profitability factors.

Dividend

ABBVRIGL
Dividend Yield 2.76% —
Payout Ratio 195.48 —

ABBV and RIGL split the dividend factors evenly.

Risk & Sentiment

ABBVRIGL
Short Interest 0.85% 42.81%

ABBV leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABBV overview, ABBV financials, RIGL overview, RIGL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.